December 2016 - Page 28 of 30

TuesdayDec 06, 2016 10:30 am

InspireMD (NSPR) Starts Presentation at LD Micro Main Event

InspireMD (NASDAQ: NSPR) is a commercial-stage medical device company marketing and developing innovative embolic prevention systems (EPS), neurovascular devices and thrombus management technologies. The company offers MGuard and MGuard prime embolic protection stents for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions; and CGuard carotid embolic prevention systems for use in carotid artery applications. InspireMD is also developing NVGuard, a neurovascular flow diverter that directs blood flow away from cerebral aneurysms to seal the aneurysms. For more information, visit the company's website at www.inspiremd.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation…

TuesdayDec 06, 2016 9:35 am

NetworkNewsWire to Provide Real-time Coverage of LD Micro Main Event 2016

NEW YORK - December 06, 2016 - NetworkNewsWire (“NNW”) announces its role as the Official Social Media Sponsor for LD Micro Main Event 2016 taking place December 6-8 in Bel Air, California. This year’s event boasts a lineup of more than 236 innovative companies from around the world – representing industries ranging from technology, biotech, pharmaceuticals, mining, energy and others – which are set to present their operations and achievements to an audience of attending investors. As a multifaceted financial news and publishing company, NNW will leverage its vast distribution capabilities to provide overview profiles in real-time, as each company…

TuesdayDec 06, 2016 9:15 am

Heron Therapeutics (HRTX) Helps Chemo Patients Prevent Vomiting with SUSTOL®

Cancer is the great scourge of our age. This year, 1.7 million Americans will find out they have the disease and some 600,000 will die from it. In total, approximately 40 percent of the population can expect to be diagnosed with cancer during their lifetime. The name “cancer” is derived from the Greek word for crab and may have been bestowed to indicate the tenacity of the disorder. Cancer tends to persist with the same relentlessness as the claws of a crab cling to a victim. Yet despite its stubbornness, cancer treatments like chemotherapy have reduced fatalities. Cancer is a…

TuesdayDec 06, 2016 7:00 am

Award-Winning Filmmaker Produces Comical Film Explaining “Why I’m Not on Pokémon Go”

From the director of the award-winning documentary “Why I’m not on Facebook” comes a satirical short film that takes a look at the digital craze of Pokémon. With more than 500 million downloads worldwide, Pokémon Go has become a “global phenomenon,” luring people of all ages to the streets – at all hours of the day – using their smartphones to locate virtual Pokémon. Launched in July of 2016, Pokémon Go became the highest-grossing app in the U.S. within 13 hours and now has more than 20 million daily active users in the United States alone. How does a 25-year…

MondayDec 05, 2016 5:31 pm

Medical Transcription Billing, Corp. (MTBC) Poised to Capitalize on Sector Growth through Integrated Cloud-Based HCIT, EHR Offerings

A recent global industry analysis and forecast report (http://nnw.fm/1pn7S) on the healthcare IT (HCIT) market by Allied Market Research, pegged the global HCIT space at around $125 billion last year, with a forward projection of 13.2 percent CAGR through 2022, when it may reach just under $300 billion. The global electronic health records (EHR) component itself was worth around $19 to $21 billion just two years ago and should see anywhere from 5.3 to 6.2 percent CAGR over the next half-decade or so, based on extant analysis by Infiniti Research (http://nnw.fm/Hiw8I), P&S Market Research (http://nnw.fm/JW6jY), and Transparency Market Research (http://nnw.fm/YTFk6).…

MondayDec 05, 2016 5:01 pm

Neuralstem, Inc. (CUR) Gets Aegis Update

Neuralstem, Inc. (NASDAQ: CUR) is a biotechnology company whose patented technology allows for the production, on a commercial level, of a number of types of central nervous stem cells. These are in the development stage for the treatment of conditions and diseases of the central nervous system. The company recently announced the start of enrollment of patients for its phase II trial of NSI-189, a drug developed after Neuralstem did research into neural stem cell lines from the human hippocampus, a part of the brain involved in memory and the generation of neurons. On November 7 of this year, Aegis…

MondayDec 05, 2016 12:27 pm

Singlepoint (SING) Subsidiary Looks to Help Cannabis Merchants Build Trust, Increase Customer Loyalty

A leading provider of mobile technology and mobile payment solutions serving various markets and industries, Singlepoint, Inc. (OTC: SING) has its eyes set on the fast-growing cannabis industry, aiming to help legal marijuana businesses build trust and increase customer loyalty via subsidiary SingleSeed and its highly reliable payment processing and marketing tools. With eight more states voting to legalize either medical or recreational marijuana use last month, the marijuana industry is set to exceed $7 billion this year and to reach roughly $20 billion by 2020. However, legal businesses operating in the sector still find it hard to obtain support…

MondayDec 05, 2016 10:56 am

Net Element, Inc. (NETE) Subsidiary PayOnline Enters Azerbaijan through Agreements with AGBank, Flight.az

Before the opening bell, Net Element, Inc. (NASDAQ: NETE), through subsidiary PayOnline, announced a new partnership with Flight.az, a subsidiary of Delta Group, Ltd that’s recognized as a leading online travel agency (OTA) in Azerbaijan. Under the terms of this contract, PayOnline integrated secure online, mobile payments acceptance functionality, as well as its proprietary ‘Avia2Split’ technology, into the OTA’s existing booking platform, giving Flight.az the tools to better serve its target market of roughly 10 million people living in Southwestern Asia. PayOnline’s newly-announced entry into the Azerbaijani market comes on the heels of a new agreement with AGBank, one of…

MondayDec 05, 2016 9:16 am

European Patent Dispute Spurs Buying Opportunity with Higher Price Target for Alder Biopharmaceuticals (ALDR)

A legal dispute with the European Patent Office over the European patent for its lead product candidate surprisingly presents a strong buying opportunity for clinical stage biopharmaceutical company Alder Biopharmaceuticals, Inc. (NASDAQ: ALDR), according to an analysis report (http://nnw.fm/8j0TO) released by Aegis Capital Corp on November 23. As such, Aegis analysts reiterated a ‘Buy’ rating for the company and proposed a higher stock price target of $41, compared to the $25.28 stock price at the time the report was issued. The report acknowledges that the ruling by the European Patent Office’s Opposition Division is unfavorable to product candidate ALD403 and…

FridayDec 02, 2016 3:44 pm

Singlepoint, Inc. (SING) CEO Discusses Influx of Calls from Cannabis Dispensaries on MoneyTV with Donald Baillargeon

Before the opening bell, Singlepoint, Inc. (OTC: SING) was announced as a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program about “money and what makes it happen.” The show includes informative interviews with company CEOs, offering prospective investors insight into their operations and outlooks for the future. To view this week’s program, visit www.MoneyTV.net In the interview, Greg Lambrecht, chief executive officer of Singlepoint, offered prospective investors an update on the progress of the company’s SingleSeed subsidiary, which it awakened from a quiet period in early November in an effort…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

Month: December 2016